Royal DSM to repurchase €205 million worth of its shares to cover share-based compensation plans and stock dividend commitments

(PRESS RELEASE) HEERLEN, the Netherlands, 10-Mar-2022 — /EuropaWire/ — Royal DSM (AMS: DSM), a global science-based company in Nutrition, Health and Sustainable Living, has announced its intention to repurchase €205 million worth of its shares (based on the closing price of the DSM ordinary share on Euronext Amsterdam on 9 March 2022) to cover share-based compensation plans and stock dividend commitments. The stock repurchase will begin on 10 March 2022 and will include 1,330,000 ordinary shares. As part of the share buyback programme 600,000 ordinary shares will be used to cover commitments under share-based compensation plans while 730,000 ordinary shares will cover commitments for stock dividend as part of the final dividend 2021.

The share buyback will be executed within the limitations of the authority granted to the Managing Board by the Annual General Meeting (AGM). The total number of ordinary shares to be repurchased under this program represents approximately 0.8% of ordinary shares issued.

DSM has signed a Discretionary Management Agreement with a bank to commence the execution of the share repurchase program on its behalf and to make trading decisions under the Agreement independently of DSM.

In accordance with regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases. The share repurchase program is anticipated to be completed in Q2 2022.

For more information

Gareth Mead
DSM Media Relations
+31 (0) 45 5782420
media.contacts@dsm.com

Dave Huizing
Vice-President Investor Relations
+31 45 578 2864
investor.relations@dsm.com

SOURCE: DSM